SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: SU11248
Sponsor: Universitaire Ziekenhuizen KU Leuven
Collaborators: Pfizer